Research and development
Flow – sum over the period · $M
Q3 FY2026
254$M
All values (16)
| Period | Value ($M) | Status |
|---|---|---|
| Q4 FY2026 | 266 | derived |
| Q3 FY2026 | 254 | reported |
| Q2 FY2026 | 258 | reported |
| Q1 FY2026 | 251 | reported |
| Q4 FY2025 | 269 | derived |
| Q3 FY2025 | 247 | reported |
| Q2 FY2025 | 240 | reported |
| Q1 FY2025 | 233 | reported |
| Q4 FY2024 | 248 | derived |
| Q3 FY2024 | 243 | reported |
| Q2 FY2024 | 229 | reported |
| Q1 FY2024 | 236 | reported |
| Q4 FY2023 | 222 | derived |
| Q3 FY2023 | 209 | reported |
| Q2 FY2023 | 204 | reported |
| Q1 FY2023 | 210 | reported |
28 periods without value hidden · Show gaps with reason · CSV with all sources · Technical ID: rnd
More metrics for ADP
Income statement
Balance sheet
Cash flow
Debt and interest
Revenue by segment/product/region
Sources & calculation
- Value
- $254M
- Period
- Q3 FY2026, ended Mar 31, 2026 · quarterly value (3 months, not cumulative)
- Source
- 10-Q, filed Apr 30, 2026 · 0000008670-26-000022
- Location
- us-gaap:ResearchAndDevelopmentExpense
- Confidence
- 1. – directly from an XBRL fact in the filing (or calculated exactly from it)
Versions
| v1 | $254M | Apr 30, 2026 | 10-Q 0000008670-26-000022 | reported · confidence 1. · current |